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A 68-year-old man presented with left testicular painless swelling. His carbohydrate antigen 19-9 and
carcinoembryonic antigen levels were elevated but his germ cell tumor markers were not high. Magnetic
resonance imaging showed multiloculated cystic lesions with solid components in his left testis. Abdominal
and chest computed tomography revealed multiple lung metastases, peritoneal dissemination and multiple
lymph node metastases. Left high orchiectomy was performed. Histopathological examination demonst-
rated testicular mucinous carcinoma with similarity to gastric cancer. Since no tumor was found by the
endoscopy of the upper gastrointestinal and the lower digestive tract, we diagnosed the patient with primary
testicular mucinous carcinoma. Standard chemotherapy for gastric cancer, which consisted of tegafur,
gimeracil and oteracil (TS-1) and cisplatin was administered for 16 months, and there was no progression of
the disease. He died from testicular mucinous cancer 30 months after the diagnosis. In the literature, only
4 cases of testicular mucinous carcinoma have been reported. TS-1 and cisplatin are useful chemother-
apeutic options for testicular mucinous carcinoma with metastasis.
(Hinyokika Kiyo 65 : 87-91, 2019 DOI : 10.14989/ActaUrolJap_65_3_87)






患 者 : 68歳，男性
主 訴 : 無痛性左陰嚢腫大，左下腹部痛
既往歴 : 特記事項なし
家族歴 : 特記事項なし




初診時現症 : 身長 165.7 cm，体重 60.8 kg
理学所見 : 左陰嚢腫大を認め，弾性硬で，圧痛を伴
* 現 : 京都府立医科大学泌尿器科学教室
** 現 : 松下記念病院腎不全科
わなかった．
検査所見 : WBC 8, 200/ μ l，Hb 14. 4 g/dl，Plt
23.2×104/μl，CRP 0.08 mg/dl，TP 7.3 g/dl，Alb 4.4
g/dl，Cre 1.14 mg/dl，BUN 18.3 mg/dl，AST 21 IU/
l，ALT 17 IU/l と軽度の腎機能障害を認めた．
腫瘍マーカー : LDH 144 IU/l，AFP 3. 3 ng/ml，
HCG 0.5 mIU/ml，HCGβ 0.1 mIU/ml，PSA 0.92 ng/
ml，CEA 70 ng/ml（基準値 : 0∼5 ng/ml），CA19-9









腫大（24 mm），多発肺結節性病変（最大径 5 mm），
腹腔内結節性病変（最大径 6 mm）を認め，傍大動脈
リンパ節腫大による左水腎症も認めた（Fig. 2）．
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Fig. 1. Images of left testis. A : An axial section of
ultrasonography showed a multiloculated
cystic lesion with the solid component. B :
A sagittal section of T1-weighted magnetic
resonance imaging with fat suppression
demonstrated a multiloculated cystic lesion.
C : A coronal section of T2-weighted mag-
netic resonance imaging indicated a multi-
loculated cystic lesion with bleeding.
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Fig. 2. Abdominal and Chest CT showed below.
A : The arrow shows paraaortic lymph node
metastasis. B : The arrow shows left renal
hilus lymph node metastasis and the white
circles show left hydronephrosis. C : The
white circle shows the tumor invasion to

























のうちシスプラチン（CDDP）を day 8 に，TS1 を
day 1-21 に投与し，day 22-35 は休薬を行うことを 1
コースとした1)．化学療法開始後，腫瘍マーカーであ
る CA19-9，CEA は低下傾向となり，CT 画像上も
RECIST 分類で SD を維持した（Fig. 5）．副作用とし
ては，投与 7コース目に grade 2（CTCAE version 4.0）
のしびれ（末梢性感覚ニューロパチー）が出現し，プ
レガバリンを開始した．また10コース目には芍薬甘草
湯を開始し，症状は grade 1-2 で経過した．11コース
目終了後，CT にて腹水の増加，腹膜播種病変の増大
を認め，化学療法開始16カ月後に PD と判定した．そ
のため胃癌のレジメンにおける 2nd line であるパクリ
タキセル（PTX）80 mg/m2 の投与を開始した．投与
スケジュールは 5週間のうち PTX を day 1，8，15 に
投与を行うことを 1 コースとした2)．しかしながら





た．投与スケジュールは 4週間のうち CPT-11 を day
1，15 に投与を行うことを 1 コースとした2)．CPT-






WHO 分類の中で，miscellaneous tumors of the testis の
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Fig. 3. Macropathological finding : Gross appearance of the multiloculated cystic tumor
showed mucinous component (A). Histopathological findings : There was mucin
around the seminiferous tubule (B) (Hematoxylin-Eosin, × 100). The tumors
showed the tubular complexes consisting of cancer cells with a high nucleocytoplasmic
ratio (C) (Hematoxylin-Eosin, ×400).
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Fig. 5. Clinical course and tumor markers.
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Fig. 4. Immunohistochemistry. The tumor cells were positive for MUC-2 (A), MUC-5AC
(B), CK 7 (C), CK 20 (D), CEA (E) and CA 19-9 (F).
Table 1. Reported primary testicular mucinous
carcinoma
年齢 術前転移 治療 転帰 著者，報告年
55 なし 高位精巣摘除 1年再発なし Teo
10) ら，
2005
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